- ?? Socially responsible vision of bringing relief to Covid sufferers in India
- ?? Formula ingredients already proven to have both prophylactic and therapeutic effects on Covid-19
- ?? Applying for registration in India to sell to an 800-million-person market of current AYUSH users
- ?? Utilizes Molecular Signaling, an innovative discovery for viral symptoms
Using a common ingredient used for decades as a preservative for vaccines, we have developed a simple spray solution for patients with viruses such as COVID-19, the common cold and flu, and even cold sores. Our safe and effective formula improves molecular signaling disrupted by these viruses and helps people feel better.
We want this product to be available in as many countries as possible. If it turns out that a current global player is in a better position to accomplish this goal, we might partner with them or be acquired.